Share this post on:

Product Name :
Ulimorelin Hydrochloride

Search keywords :
Ulimorelin

drugId :
null

Target Vo:
Ghrelin/growth hormone secretagogue receptor

Target Vo Short Name :
GHSR

Moa_Name:
Ghrelin/growth hormone secretagogue receptor agonists

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Ocera Therapeutics Inc

Active Company_Name :

Active Indication_Name:

In Active Indication_Name:
Intestinal Obstruction

Termination Status :
Phase 3 Clinical

China Termination Status :

Highest Status:
Pending

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Semorinemab Tau Protein
Farletuzumab manufacturer
FCGR1A Antibody: FCGR1A Antibody is an unconjugated, approximately 43 kDa, rabbit-derived, anti-FCGR1A monoclonal antibody. FCGR1A Antibody can be used for: WB, IHC-P, FC expriments in human background without labeling.

Share this post on:

Author: Interleukin Related